Preparing HF validation reports that satisfy FDA reviewers for combination products

Preparing HF Validation Reports that Satisfy FDA Reviewers for Combination Products Preparing HF Validation Reports that Satisfy FDA Reviewers for Combination Products The integration of human factors engineering (HFE) practices in the development of combination products is vital to ensure that the end users can safely and effectively use these products. In light of regulatory expectations set forth by the FDA, this article provides a comprehensive guide for regulatory professionals on how to prepare human factors validation reports that fulfill FDA reviewers’ criteria. Emphasis will also be placed on collaboration across various sectors including Chemistry, Manufacturing and Controls (CMC), Clinical,…

Continue Reading... Preparing HF validation reports that satisfy FDA reviewers for combination products

Common human factors engineering pitfalls in combination product usability studies

Common human factors engineering pitfalls in combination product usability studies Common Human Factors Engineering Pitfalls in Combination Product Usability Studies Regulatory Affairs Context The integration of human factors engineering (HFE) into the development of combination products and devices is of paramount importance to ensure patient safety and product effectiveness. The FDA defines combination products as those that involve a combination of drug, device, and/or biological product components. Regulatory Affairs (RA) professionals play a critical role in navigating the complex landscape of regulations and guidelines, particularly concerning FDA human factors engineering expectations. As outlined by the FDA, compliance with usability engineering…

Continue Reading... Common human factors engineering pitfalls in combination product usability studies

Regulatory strategy for human factors submissions in NDA/BLA combination products

Regulatory strategy for human factors submissions in NDA/BLA combination products Regulatory strategy for human factors submissions in NDA/BLA combination products The integration of human factors engineering (HFE) into the development of combination products is essential for ensuring usability, safety, and efficacy. Understanding and implementing a regulatory strategy for human factors submissions in New Drug Applications (NDA) and Biologics License Applications (BLA) is critical for regulatory affairs professionals in the pharmaceutical and biotech industries. This article provides a comprehensive overview of the relevant regulations, guidelines, agency expectations, and practical approaches to managing human factors engineering in combination products, particularly in the…

Continue Reading... Regulatory strategy for human factors submissions in NDA/BLA combination products

Vendor oversight for combination product human factors engineering activities

Vendor Oversight for Combination Product Human Factors Engineering Activities Vendor Oversight for Combination Product Human Factors Engineering Activities Human Factors Engineering (HFE) is a critical aspect of the development of combination products and medical devices, ensuring that the end user can effectively and safely use the product. For Regulatory Affairs (RA) professionals, understanding the regulatory framework surrounding HFE and how to appropriately oversee vendors conducting related activities is paramount in achieving compliance and successful market authorization. This article serves as a practical guide, detailing the relevant regulations, documentation requirements, and agency expectations concerning FDA human factors engineering and vendor oversight…

Continue Reading... Vendor oversight for combination product human factors engineering activities

Incorporating patient feedback into FDA human factors engineering for devices

Incorporating patient feedback into FDA human factors engineering for devices Incorporating Patient Feedback into FDA Human Factors Engineering for Devices Context The integration of human factors engineering (HFE) into the design and evaluation of combination products and devices is critical for enhancing usability and ensuring patient safety. In the regulatory landscape of the US, the FDA emphasizes user-centered design principles in the development of these products. This article provides an in-depth analysis of FDA expectations regarding human factors engineering, focusing on how patient feedback can be effectively incorporated to produce safer, more effective devices. Legal/Regulatory Basis The FDA human factors…

Continue Reading... Incorporating patient feedback into FDA human factors engineering for devices

Global alignment of FDA human factors engineering with EU MDR and UKCA requirements

Global alignment of FDA human factors engineering with EU MDR and UKCA requirements Global Alignment of FDA Human Factors Engineering with EU MDR and UKCA Requirements The integration of human factors engineering (HFE) into the design and development of combination products and medical devices is a critical component that ensures safety and efficacy. This article provides a detailed exploration of the regulatory landscape surrounding FDA human factors engineering and its alignment with the European Union Medical Device Regulation (EU MDR) and UK Conformity Assessment (UKCA) marking requirements. It serves as a comprehensive guide for regulatory affairs professionals as they navigate…

Continue Reading... Global alignment of FDA human factors engineering with EU MDR and UKCA requirements

How to perform use-error risk analysis for complex drug delivery devices

How to perform use-error risk analysis for complex drug delivery devices How to perform use-error risk analysis for complex drug delivery devices Context In the realm of pharmaceutical and medical device development, human factors and operator qualification are paramount. The increasing complexity of drug delivery systems necessitates a focus on user interactions, particularly in avoiding use errors that could have significant clinical implications. Regulatory affairs (RA) professionals play a critical role in ensuring compliance with international standards such as ISO 14971, which provides a framework for risk management in the medical device sector, including methods like use-error risk analysis. Legal/Regulatory…

Continue Reading... How to perform use-error risk analysis for complex drug delivery devices

Task mapping and critical-user step identification for combination products

Task mapping and critical-user step identification for combination products Task Mapping and Critical-User Step Identification for Combination Products In the rapidly evolving field of regulatory affairs, particularly for combination products, a robust framework addressing human factors and use-error risk analysis is vital. This article will provide a structured explanation of the regulations, guidelines, and agency expectations pertinent to task mapping and critical-user step identification. Regulatory Affairs Context Combination products are therapeutic approaches that combine different modalities, such as drugs, devices, and biological products. With their complexity comes increased risk potential; hence, regulatory agencies enforce stringent guidelines to mitigate use-errors. Understanding…

Continue Reading... Task mapping and critical-user step identification for combination products

Using FMEA for human factors and use-error risk analysis in medical devices

Using FMEA for Human Factors and Use-Error Risk Analysis in Medical Devices Using FMEA for Human Factors and Use-Error Risk Analysis in Medical Devices In the dynamic field of medical device regulation, thorough analysis of human factors and potential use errors is paramount to ensure patient safety and compliance with applicable regulations. This article serves as a comprehensive guide for regulatory affairs professionals, detailing the use-error risk analysis, particularly utilizing Failure Mode and Effects Analysis (FMEA) methodology, to address human factors issues in medical device validation. Regulatory Context for Human Factors and Use-Error Risk Analysis Understanding the landscape of clinical…

Continue Reading... Using FMEA for human factors and use-error risk analysis in medical devices

Designing risk-based mitigation plans for critical use errors in injectors

Designing risk-based mitigation plans for critical use errors in injectors Designing risk-based mitigation plans for critical use errors in injectors Regulatory Affairs Context The application of regulatory frameworks to human factors engineering and risk management is critical in the lifecycle of medical devices, specifically injectors. Regulatory authorities such as the FDA, EMA, and MHRA stipulate stringent guidelines to assure that devices do not only function as intended but that they also account for human interaction. The use-error risk analysis serves as a fundamental mechanism to assess potential misuse and ensure the safety and effectiveness of injector systems. Legal/Regulatory Basis When…

Continue Reading... Designing risk-based mitigation plans for critical use errors in injectors